Announcing the fourth Annual National Hemophilia Foundation Annual Meeting Pre-Conference Symposium, Enhancing the Value of Managed Care and Specialty Pharmacy within the Hemophilia Comprehensive Care Model

NEW YORK–(BUSINESS WIRE)– The National Hemophilia Foundation (NHF) and Impact Education, LLC
(IMPACT) are pleased to announce the fourth annual pre-conference
symposium specifically designed for specialty pharmacists, home health
pharmacists, health plan pharmacists, managed Medicaid pharmacists,
medical directors, and other healthcare professionals with an interest
in the management of patients with hemophilia. This free,
CME/CPE-certified activity is scheduled to take place on July 21,
2016 from 1:45 PM – 5:00 PM EDT at the Gaylord Palms Resort & Convention
Center in Orlando, Florida, in conjunction with NHF’s 68^th
Annual Meeting, “A Brighter Future Together.”

Hemophilia is an expensive chronic condition with total annual costs
that can average $250,000 or more for severe patients. Optimal
outcomes require a collaborative and coordinated patient experience. The
collaborative team can include an insurer, Hemophilia Treatment Center
(HTC), and specialty pharmacy. Specialty pharmacy services can support
patient adherence to treatment and assist physicians, plans, and
employers in meeting clinical and/or financial goals. This symposium
features a multidisciplinary expert panel, including a Specialty
Pharmacist Expert, leading Hematologist, Hemophilia Treatment Center
Nurse Coordinator, and a Managed Care Pharmacy Director. The program
will provide an advanced clinical update and emphasize the need for
well-coordinated treatment management, best practices to integrate
hemophilia care with payer policies, and the value of having
collaboration among all stakeholders.

Register today at http://www.impactedu.net/specialtypharmacy16;
space is limited. The symposium is jointly provided by NHF, IMPACT,
and the Postgraduate Institute for Medicine, and is supported by
independent educational grants from Baxalta US Inc., Grifols, and Novo
Nordisk, Inc.

About the National Hemophilia Foundation

The National
Hemophilia Foundation (NHF) is dedicated to finding better
treatments and cures for inheritable bleeding disorders and to
preventing the complications of these disorders through education,
advocacy and research. Established in 1948, NHF is based in New York
City with 51 chapters throughout the United States. NHF’s programs,
initiatives and events are made possible through the generosity of
individuals, corporations and foundations as well as through a
cooperative agreement with the Centers for Disease Control and
Prevention (CDC). For more information, visit the National
Hemophilia Foundation Web site and follow us on Facebook
and Twitter.

About Impact Education, LLC

IMPACT is an independent medical education and communications
company dedicated to providing high quality educational programs. IMPACT’s
mission is to develop education that improves patient outcomes in
combination with increased health care efficiency and
cost-effectiveness. The majority of activities developed by IMPACT
are focused on the needs of the managed care and payer audiences. IMPACT
has received the Alliance for CME Award for Outstanding
Collaboration, which recognizes organizations that best demonstrate
innovation or uniqueness in achieving effective CME/CE collaboration.
For more information, visit www.impactedu.net
and follow us on Facebook
and Twitter.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160519006154/en/